A DEA hearing to consider moving all cannabis products to Schedule III concluded on July 15 but a judicial recommendation has yet to be issued
“A ‘legitimate medical explanation’ requires use of a legally prescribed controlled substance in compliance with federal laws governing such a prescription.”
From federal licensing and registration to an expedited review process, these are the basics
The agency has been consistent in its interpretation of the law, but federal courts have disagreed
Assoc. professor of nursing who studies cannabis breaks down some of the possibilities moving forward in a rescheduled world
An update on the Trump administration’s rescheduling announcement
The order also states that “unlicensed bulk marijuana” remains classified as a Schedule I controlled substance
“This action recognizes the longstanding regulation of medical marijuana by state governments and the need for a common-sense approach to this reality.”
The two main subjects up for discussion in DC were the appropriation bill that redefined “hemp,” and the movement of marijuana to Schedule III
Featuring experts from Mass General Hospital and the Cannabis Chamber of Commerce, among other institutions
